SELECTIVE INHIBITION OF THE MASTER REGULATOR TRANSCRIPTION FACTOR EGR-1 USING CATALYTIC OLIGONUCLEOTIDES REDUCES MYOCARDIAL INJURY AND IMPROVES LV SYSTOLIC FUNCTION IN A PRECLINICAL MODEL OF MYOCARDIAL INFARCTION  by Rayner, Benjamin et al.
Acute Coronary Syndromes 
E213
JACC March 12, 2013
Volume 61, Issue 10
selecTive inhiBiTion of The masTer regulaTor TranscripTion facTor egr-1 using caTalyTic 
oligonucleoTides reduces myocardial injury and improves lv sysTolic funcTion in a 
preclinical model of myocardial infarcTion
Poster Contributions
Poster Sessions, Expo North
Monday, March 11, 2013, 9:45 a.m.-10:30 a.m.
Session Title: Acute Coronary Syndromes: Basic V
Abstract Category: 2. Acute Coronary Syndromes: Basic
Presentation Number: 1300-189
Authors: Benjamin Rayner, Gemma Figtree, William Lay, Tharani Sabaretnam, Ping Shang, Jawad Mazhar, James Weaver, Stuart Grieve, Stephen 
Hunyor, Levon Khachigian, Ravinay Bhindi, University of Sydney, Sydney, Australia, Royal North Shore Hospital, Sydney, Australia
Background: Egr-1 is implicated in the pathogenesis of myocardial ischemia reperfusion (I/R) injury. The aim of this study was to ascertain the 
effectiveness of the delivery of DNAzyme specifically targeted against Egr-1 transcription at reperfusion following myocardial ischemia.
methods: Pigs (30-40kg) were subjected to balloon occlusion of the left anterior descending (LAD) coronary artery for 60 min, followed by 
reperfusion and recovery. Pigs received functional DNAzyme (DZF) targeting Egr-1 or a size-matched scrambled control (DZFScr) via intracoronary 
delivery immediately upon reperfusion. At 48 h post-I/R, 3-T cardiac magnetic resonance imaging (MRI) was performed and comparative analysis of 
ejection fraction (EF) and percentage of salvaged heart tissue determined. Echocardiography was performed and left ventricular (LV) fractional area 
change (FAC) determined. Following the in vivo studies, hearts were excised and examined for molecular and histological markers of inflammation 
including ICAM-1, VCAM-1, tissue factor (TF), and apoptotic markers including p53, PTEN, and Complement 3.
results: Delivery of DZF led to the significant decrease in the expression of the ICAM-1, VCAM-1, TF, p53, PTEN, and complement 3. Furthermore, 
within the DZF treated group there was a significant 29% increase in EF volume coupled with 40% increase in FAC and 82% increased LV salvage 
compared to the DZFScr group.
conclusions: Silencing of Egr-1 through the intracoronary delivery of DNAzymes immediately upon reperfusion following acute myocardial I/R 
injury decreases markers of inflammation and apoptosis within the heart tissue and subsequently reduces cardiac tissue damage and dysfunction 
following I/R injury.
